NCT01319773 - Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Dry Eye Syndromes

Interventions

DRUG

cyclosporine ophthalmic emulsion Formulation A

One drop of cyclosporine ophthalmic emulsion Formulation A administered to each eye twice daily for 2 days and once in the morning of Day 3.

DRUG

cyclosporine ophthalmic emulsion Formulation B

One drop of cyclosporine ophthalmic emulsion Formulation B administered to each eye twice daily for 2 days and once in the morning of Day 3.

DRUG

cyclosporine ophthalmic emulsion Formulation A; cyclosporine ophthalmic emulsion 0.05%

One drop of cyclosporine ophthalmic emulsion Formulation A administered to one eye and one drop of cyclosporine ophthalmic emulsion 0.05% administered to the opposite eye, twice daily for 1 day.

DRUG

cyclosporine ophthalmic emulsion Formulation B; cyclosporine ophthalmic emulsion 0.05%

One drop of cyclosporine ophthalmic emulsion Formulation B administered to one eye and one drop of cyclosporine ophthalmic emulsion 0.05% administered to the opposite eye, twice daily for 1 day.

DRUG

cyclosporine ophthalmic emulsion Formulation A; cyclosporine ophthalmic emulsion Formulation B

One drop of cyclosporine ophthalmic emulsion Formulation A administered to one eye and one drop of cyclosporine ophthalmic emulsion Formulation B administered to the opposite eye, twice daily for 1 day.

Trial Locations (1)

Unknown

Newport Beach